Plymouth, MN, United States of America

Nandita Bose

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Nandita Bose: Innovator in Immunopharmacology

Introduction

Nandita Bose is a prominent inventor based in Plymouth, MN (US), known for her significant contributions to the field of immunopharmacology. With a total of 12 patents to her name, she has made remarkable strides in understanding the interactions between β-glucan and immune cells. Her innovative approaches have the potential to enhance immunotherapy treatments.

Latest Patents

One of her latest patents focuses on methods for identifying β-glucan binding to immune cells. This method involves obtaining a blood sample from a subject, adding soluble β-glucan, and incubating the mixture to allow binding. The process culminates in detecting the bound β-glucan. Another significant patent addresses beta-glucan immunopharmacodynamics, providing dosing strategies for soluble β-glucan immunotherapy. This patent outlines methods for analyzing biological samples to identify appropriate dosing strategies based on biomarker levels.

Career Highlights

Throughout her career, Nandita has worked with notable companies such as Biothera Inc. and Hibercell, Inc. Her work has been instrumental in advancing the understanding of immune responses and developing effective immunotherapies.

Collaborations

Nandita has collaborated with esteemed colleagues, including Keith B. Gorden and William J. Grossman, contributing to a rich exchange of ideas and innovations in her field.

Conclusion

Nandita Bose's work exemplifies the intersection of innovation and healthcare, particularly in the realm of immunopharmacology. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…